The InnoSIGN team is committed to transform cancer care by enabling personalized targeted therapy options through OncoSIGNal pathway activity profiling. Our team has a wealth of experience in bringing innovative diagnostic solutions to the market.

  • revolutionizing precision medicine

Board of Directors

Allan May

Chairman - Life Science Angels

Evan Castiglia

Thuja Capital

Mark Oldroyd

Independent Board Member

Eric Lindquist


Paul Vernooij

Observer BOM

Benno Tieke

Observer Philips

Paul van de Wiel

Observer InnoSIGN

Meet the team

Eric Lindquist

Chief Executive Officer

Paul van de Wiel

Chief Operating Officer

Sigi Neerken

Chief Business Officer

Eveline den Biezen

Chief Scientific Officer

Anke Pierik

Chief Technology Officer

Robert Babkowski MD

CLIA Lab Medical Director

Anne van Brussel

Application Scientist

Sandra Gunselman

Director CLIA Lab Operations

Laurent Holtzer

Solutions Architect

Diederick Keizer

Clinical Operation Manager

Marianna Polonsky

VP of Market Access & Commercial Strategy

Dianne van Strijp

Product Application Specialist

Gwen Sülter

MARCOM Specialist

Saskia Vermeer

Service Lab Manager

Yvonne Wesseling-Rozendaal

Clinical Data Scientist

Janneke Wrobel

Quality Engineer

Martijn van Zelst

Operations Lead